Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - PALISADE BIO, INC. | v441791_8k.htm |
Exhibit 16.01
June 6, 2016
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Ladies and Gentlemen:
We have read Neuralstem, Inc.’s (the “Company”) disclosure set forth in Item 4.01(a), “Changes in Registrant’s Certifying Accountant”, in its Current Report on Form 8-K dated June 6, 2016 and are in agreement with such statements concerning our firm. We have no basis to, and therefore, do not agree or disagree with the other statements made by the Company in the Current Report on Form 8-K.
Sincerely,
/s/ Stegman & Company